31 Mar 2019
Assets298.18
Total Income311.53
EBITDA37.74
Profit After Tax63.82
NET Worth193.59
Reserves and Surplus187.17
Total Borrowing29.91
At a glance
Updated 2026-08-23Windlas Biotech is a Mainboard IPO with an issue size of ₹401.54 crore, proposed for listing on BSE, NSE. The offer opens on 4th Aug 2021 and closes on 6th Aug 2021. The issue structure includes a fresh issue of ₹165.00 crore and an offer-for-sale component of ₹236.54 crore. The current listing schedule points to 16th Aug 2021.
Issue details
Listing atBSE, NSE
Issue typeBook Build Issue
Issue size₹401.54 Cr
Fresh issue₹165.00 Cr
Offer for sale₹236.54 Cr
Face value₹5
Price band₹448.00–₹460.00
Allotment11th Aug 2021
Listing16th Aug 2021
Grey market
GMP page ↗Latest GMP₹80.00
GMP / upper price17.39%
Est. listing₹540.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens4th Aug 2021
Closes6th Aug 2021
Allotment11th Aug 2021
Refund12th Aug 2021
Demat13th Aug 2021
Listing16th Aug 2021
Subscription demand
Full bidding ↗Total22.44×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 30 | ₹13,800 |
Company
Incorporated2001
Use of proceeds
| Object | Amount |
|---|---|
| Purchase of equipment required for (i) capacity expansion of the existing facility at the Dehradun Plant – IV; and (ii) addition of injectables dosage capability at our existing facility at Dehradun Plant – II | ₹50.00 Cr |
| Funding incremental working capital requirements of the Company | ₹47.56 Cr |
| Repayment/prepayment of certain of the borrowings | ₹20.00 Cr |
| General corporate purposes( | ₹34.60 Cr |
Financials
Full financials ↗31 Mar 2020
Assets338.49
Total Income331.34
EBITDA34.00
Profit After Tax16.21
NET Worth209.66
Reserves and Surplus203.25
Total Borrowing27.43
31 Mar 2021
Assets296.12
Total Income430.70
EBITDA54.52
Profit After Tax15.57
NET Worth199.12
Reserves and Surplus192.71
Total Borrowing31.32
Trend chart₹ crore
KPIs
| KPI | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Book Running Lead Managers’ fees | 12.12 |
| 2 | Commission/processing fee for SCSBs and the Banker to the Offer. Brokerage, underwriting commission and selling commission and bidding charges for Members of the Syndicate, Registered Brokers, RTAs and CDPs | 5.55 |
| 3 | Fees payable to the Registrar to the Offer | 0.28 |
| 4 | Fees payable to the other advisors to the Offer | 1.16 |
| 5 | Listing fees, SEBI filing fees, upload fees, BSE & NSE processing fees, book building software fees and other regulatory expenses | 3.07 |
| 6 | Printing and stationery | 1.29 |
| 7 | Advertising and marketing expenses | 1.99 |
| 8 | Fee payable to legal counsels | 3.98 |
| 9 | Miscellaneous | 0.74 |
Issue expenses
| Expense | Amount |
|---|---|
| Book Running Lead Managers’ fees | ₹12.12 Cr |
| Commission/processing fee for SCSBs and the Banker to the Offer. Brokerage, underwriting commission and selling commission and bidding charges for Members of the Syndicate, Registered Brokers, RTAs and CDPs | ₹5.55 Cr |
| Fees payable to the Registrar to the Offer | ₹0.28 Cr |
| Fees payable to the other advisors to the Offer | ₹1.16 Cr |
| Listing fees, SEBI filing fees, upload fees, BSE & NSE processing fees, book building software fees and other regulatory expenses | ₹3.07 Cr |
| Printing and stationery | ₹1.29 Cr |
| Advertising and marketing expenses | ₹1.99 Cr |
| Fee payable to legal counsels | ₹3.98 Cr |
| Miscellaneous | ₹0.74 Cr |
Registrar & lead managers
Registrar
MUFG Intime India Pvt.Ltd.Lead managers
- SBI Capital Markets Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-08-23.